UBS lowered the firm’s price target on Molina Healthcare (MOH) to $170 from $180 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $180 from $210 at Cantor Fitzgerald
- Molina Healthcare price target lowered to $167 from $207 at Goldman Sachs
- Molina Healthcare price target lowered to $165 from $203 at Deutsche Bank
- Molina Healthcare downgraded to Underweight from Equal Weight at Barclays
- Molina Healthcare’s Q3 2025 Financial Performance Overview